88 related articles for article (PubMed ID: 25231954)
1. Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.
Birch SE; Kench JG; Takano E; Chan P; Chan AL; Chiam K; Veillard AS; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB
Ann Oncol; 2014 Dec; 25(12):2392-2397. PubMed ID: 25231954
[TBL] [Abstract][Full Text] [Related]
2. E6AP promotes the degradation of the PML tumor suppressor.
Louria-Hayon I; Alsheich-Bartok O; Levav-Cohen Y; Silberman I; Berger M; Grossman T; Matentzoglu K; Jiang YH; Muller S; Scheffner M; Haupt S; Haupt Y
Cell Death Differ; 2009 Aug; 16(8):1156-66. PubMed ID: 19325566
[TBL] [Abstract][Full Text] [Related]
3. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
4. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
Paul PJ; Raghu D; Chan AL; Gulati T; Lambeth L; Takano E; Herold MJ; Hagekyriakou J; Vessella RL; Fedele C; Shackleton M; Williams ED; Fox S; Williams S; Haupt S; Gamell C; Haupt Y
Oncogene; 2016 Dec; 35(48):6235-6245. PubMed ID: 27641331
[TBL] [Abstract][Full Text] [Related]
5. Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation.
Sewatanon J; Ling PD
Virology; 2013 Jun; 440(2):140-9. PubMed ID: 23541081
[TBL] [Abstract][Full Text] [Related]
6. E6AP promotes prostate cancer by reducing p27 expression.
Raghu D; Paul PJ; Gulati T; Deb S; Khoo C; Russo A; Gallo E; Blandino G; Chan AL; Takano E; Sandhu SK; Fox SB; Williams S; Haupt S; Gamell C; Haupt Y
Oncotarget; 2017 Jun; 8(26):42939-42948. PubMed ID: 28477016
[TBL] [Abstract][Full Text] [Related]
7. Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Gulati T; Huang C; Caramia F; Raghu D; Paul PJ; Goode RJA; Keam SP; Williams SG; Haupt S; Kleifeld O; Schittenhelm RB; Gamell C; Haupt Y
Mol Cell Proteomics; 2018 Jun; 17(6):1170-1183. PubMed ID: 29463595
[TBL] [Abstract][Full Text] [Related]
8. Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Gurrieri C; Capodieci P; Bernardi R; Scaglioni PP; Nafa K; Rush LJ; Verbel DA; Cordon-Cardo C; Pandolfi PP
J Natl Cancer Inst; 2004 Feb; 96(4):269-79. PubMed ID: 14970276
[TBL] [Abstract][Full Text] [Related]
9. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
[TBL] [Abstract][Full Text] [Related]
12. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
13. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
[TBL] [Abstract][Full Text] [Related]
14. Androgen suppresses PML protein expression in prostate cancer CWR22R cells.
Yang L; Yeh SD; Xie S; Altuwaijri S; Ni J; Hu YC; Chen YT; Bao BY; Su CH; Chang C
Biochem Biophys Res Commun; 2004 Jan; 314(1):69-75. PubMed ID: 14715247
[TBL] [Abstract][Full Text] [Related]
15. Loss of promyelocytic leukemia protein in human gastric cancers.
Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
[TBL] [Abstract][Full Text] [Related]
16. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
17. The RING domain of human promyelocytic leukemia protein (PML).
Huang SY; Chang CF; Fang PJ; Naik MT; Güntert P; Shih HM; Huang TH
J Biomol NMR; 2015 Feb; 61(2):173-80. PubMed ID: 25627356
[No Abstract] [Full Text] [Related]
18. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.
He D; Mu ZM; Le X; Hsieh JT; Pong RC; Chung LW; Chang KS
Cancer Res; 1997 May; 57(10):1868-72. PubMed ID: 9157977
[TBL] [Abstract][Full Text] [Related]
19. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
20. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]